Dare Bioscience, Inc. (DARE) stock
DARENasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.43−0.16 (-26.57%)
Close on Nov 17, 2026Market cap $6.56MP/E –Yield –
Dare Bioscience price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Dare Bioscience's price to book ratio was 24.2× on Jul 31, 2026, against 12.9× a year earlier. Over the last 5 years it ranged from 1.4× to 160.1×, with a median of 8.1×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Jul 31, 2026 | 24.2× | +14.8 |
| 2025 | Dec 31, 2025 | 9.4× | −150.7 |
| 2024 | Oct 31, 2024 | 160.1× | +147.1 |
| 2023 | Jul 31, 2023 | 12.9× | +10.3 |
| 2022 | Dec 30, 2022 | 2.6× | −2.2 |
| 2021 | Dec 31, 2021 | 4.8× | −83.4 |
| 2020 | Oct 30, 2020 | 88.2× | +80.6 |
| 2019 | Dec 31, 2019 | 7.6× | +6.7 |
| 2018 | Dec 31, 2018 | 0.8× | +0.3 |
| 2017 | Dec 29, 2017 | 0.6× | −0.6 |
| 2016 | Dec 30, 2016 | 1.2× | −0.1 |
| 2015 | Dec 31, 2015 | 1.3× | −1.1 |
| 2014 | Dec 31, 2014 | 2.4× | – |
See a number that looks wrong?